Detection of Brain Cancer Using Genome-wide Cell-free DNA Fragmentomes
Authors:
- Dimitrios MathiosDMDimitrios Mathios
- Noushin NiknafsNNNoushin Niknafs
- Akshaya V. AnnapragadaAAAkshaya V. Annapragada
- Ernest J. BobeffEBErnest J. Bobeff
- Elaine J. ChiaoECElaine J. Chiao
- Kavya BoyapatiKBKavya Boyapati
- Keerti BoyapatiKBKeerti Boyapati
- Sarah ShortSSSarah Short
- Adrianna L. BartolomucciABAdrianna L. Bartolomucci
- Stephen CristianoSCStephen Cristiano
- Shashikant KoulSKShashikant Koul
- Nicholas A. VulpescuNVNicholas A. Vulpescu
Open Access
- 29 April 2025
- journal article
- biomarkers
- Published by American Association for Cancer Research (AACR) in Cancer Discovery
- Vol. 15 (8) , 1593-1608
Abstract
Diagnostic delays in patients with brain cancer are common and can impact patient outcome. Development of a blood-based assay for detection of brain cancers could accelerate brain cancer diagnosis. In this study, we analyzed genome-wide cell-free (cfDNA) fragmentomes, including fragmentation profiles and repeat landscapes, from the plasma of individuals with (n = 148) or without (n = 357) brain cancer. Machine learning analyses of cfDNA fragmentome features detected brain cancer across all-grade gliomas (AUC = 0.90; 95% confidence interval, 0.87–0.93), and these results were validated in an independent prospectively collected cohort. cfDNA fragmentome changes in patients with gliomas represented a combination of fragmentation profiles from glioma cells and altered white blood cell populations in the circulation. These analyses reveal the properties of cfDNA in patients with brain cancer and open new avenues for noninvasive detection of these individuals. Significance: Brain cancer is one of the deadliest and most challenging cancers to detect with liquid biopsy approaches in blood, hampering efforts for earlier noninvasive diagnosis. We have developed a machine learning genome-wide cfDNA fragmentation method that provides a sensitive and accessible approach for brain cancer detection.Keywords
All Related Versions
Funding Information
- Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
- Gray Foundation
- Commonwealth Foundation for Cancer Research Foundation
- Mark Foundation For Cancer Research
- Conquer Cancer Foundation
- Cole Foundation
- Center for Cancer Research (CA121113, CA233259, CA271896)
- Center for Cancer Research (CA006973)
- Center for Cancer Research (CA062924)
- Center for Cancer Research (1T32GM136577)
- Center for Cancer Research (T32GM148383)
- American Association for Cancer Research (20-40-31-MATT)
This publication has 63 references indexed in Scilit:
- Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome SequencingScience Translational Medicine, 2012
- Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trialThe Lancet Oncology, 2012
- A fast, lock-free approach for efficient parallel counting of occurrences of k-mersBioinformatics, 2011
- BEDTools: a flexible suite of utilities for comparing genomic featuresBioinformatics, 2010
- What Happens to New-Onset Headache Presented to Primary Care? A Case-Cohort Study Using Electronic Primary Care RecordsCephalalgia, 2008
- Increased Regulatory T-Cell Fraction Amidst a Diminished CD4 Compartment Explains Cellular Immune Defects in Patients with Malignant GliomaCancer Research, 2006
- Early symptoms of brain tumoursJournal of Neurology, Neurosurgery & Psychiatry, 2004
- Lumbar puncture and the risk of herniation: when should we first perform CT?Journal of Neurology, 2002
- COMPLICATIONS OF LUMBAR PUNCTURENeurologic Clinics, 1998
- Delay in the Diagnosis of Pediatric Brain TumorsArchives of Pediatrics & Adolescent Medicine, 1986